Physician profile
Marie Blacker
NPI 1326521543
$2,157.28
in general payments reported to CMS, 2019-2025
12 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,830 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,322 · Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,321.66 |
| Food and Beverage | $835.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,500.81 | 2024-2025 | Spravato |
| Abbvie INC. | $198.69 | 2024-2025 | |
| Tris Pharma INC | $160.27 | 2024-2025 | Dyanavel Xr |
| Neurocrine Biosciences, INC. | $72.41 | 2024-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $56.54 | 2024 | Fanapt |
| Axsome Therapeutics, INC. | $44.41 | 2024 | Auvelity, Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $42.99 | 2025 | Trintellix |
| Ironshore Pharmaceuticals INC. | $21.28 | 2024 | |
| Noven Therapeutics, LLC | $16.00 | 2024 | Xelstrym |
| Bausch Health US, LLC | $14.88 | 2024 | Aplenzin |
| Corium, LLC | $14.83 | 2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $14.17 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Blacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.